BioCentury
ARTICLE | Company News

Merck KGaA shuffles management team

September 28, 2013 1:00 AM UTC

Merck KGaA (Xetra:MRK) said Belen Garijo, currently COO of Merck Serono S.A., Merck's biopharmaceutical division, will succeed Stefan Oschmann as president and CEO of the division, effective Oct. 1. Oschmann, who remains a director, will focus on his role as head of pharmaceuticals, in which he will oversee the Merck Serono and consumer health divisions, as well as the Allergopharma GmbH & Co. KG and biosimilars units. ...